<?xml version='1.0' encoding='utf-8'?>
<document id="7645546"><sentence text="Apophysomyces elegans infection in a renal transplant recipient." /><sentence text="A 50-year-old cadaveric renal transplant recipient on immunosuppressive therapy is described with post-traumatic cutaneous infection caused by Apophysomyces elegans" /><sentence text=" He showed no evidence of hematogenous dissemination and recovered fully after therapy with extensive local debridement and amphotericin B lipid complex"><entity charOffset="124-138" id="DDI-PubMed.7645546.s3.e0" text="amphotericin B" /></sentence><sentence text=" An apparent drug-drug interaction between amphotericin B lipid complex and cyclosporine was encountered"><entity charOffset="43-57" id="DDI-PubMed.7645546.s4.e0" text="amphotericin B" /><entity charOffset="76-88" id="DDI-PubMed.7645546.s4.e1" text="cyclosporine" /><pair ddi="false" e1="DDI-PubMed.7645546.s4.e0" e2="DDI-PubMed.7645546.s4.e0" /><pair ddi="false" e1="DDI-PubMed.7645546.s4.e0" e2="DDI-PubMed.7645546.s4.e1" /></sentence><sentence text=" The course of A elegans infection in transplant recipients may be similar to that described in immunocompetent hosts" /><sentence text=" A elegans infection should be considered in evaluation of post-traumatic cutaneous infection not readily responsive to antibacterial therapy" /><sentence text="" /></document>